Cargando…
P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428795/ http://dx.doi.org/10.1097/01.HS9.0000969636.32603.d4 |
| _version_ | 1785090555581038592 |
|---|---|
| author | Lang, Fabian Branford, Susan P. Lyssikatos, Joseph Collins, Helen Hochhaus, Andreas |
| author_facet | Lang, Fabian Branford, Susan P. Lyssikatos, Joseph Collins, Helen Hochhaus, Andreas |
| author_sort | Lang, Fabian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428795 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104287952023-08-17 P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES Lang, Fabian Branford, Susan P. Lyssikatos, Joseph Collins, Helen Hochhaus, Andreas Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428795/ http://dx.doi.org/10.1097/01.HS9.0000969636.32603.d4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Lang, Fabian Branford, Susan P. Lyssikatos, Joseph Collins, Helen Hochhaus, Andreas P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_full | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_fullStr | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_full_unstemmed | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_short | P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES |
| title_sort | p683: trials in progress: first-in-human study of elvn-001, a selective bcr::abl1 tyrosine kinase inhibitor, in patients with chronic myeloid leukemia who failed previous tyrosine kinase inhibitor therapies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428795/ http://dx.doi.org/10.1097/01.HS9.0000969636.32603.d4 |
| work_keys_str_mv | AT langfabian p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies AT branfordsusan p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies AT plyssikatosjoseph p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies AT collinshelen p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies AT hochhausandreas p683trialsinprogressfirstinhumanstudyofelvn001aselectivebcrabl1tyrosinekinaseinhibitorinpatientswithchronicmyeloidleukemiawhofailedprevioustyrosinekinaseinhibitortherapies |